Dietary supplementation of glucosamine sulfate attenuates intestinal inflammation in a mouse model of experimental colitis.

Publication Type:

Journal Article

Source:

Journal of gastroenterology and hepatology (2013)

Keywords:

2013, January 2014, Public Health Sciences Division

Abstract:

Epidemiological evidences suggested an inverse association between the use of glucosamine supplements and colorectal cancer (CRC) risk. In this study, the efficacy of glucosamine to attenuate dextran sodium sulfate (DSS)-induced colitis, a precancerous condition for CRC was evaluated.